https://medicalxpress.com/news/2025-03-naturally-molecule-rivals-ozempic-weight.html logotype Topics Conditions * Week's top * Latest news * Unread news * Subscribe [ ] Science X Account [ ] [ ] [*] Remember me Sign In Click here to sign in with or Forget Password? Not a member? Sign up Learn more * Addiction * Alzheimer's disease & dementia * Arthritis & Rheumatism * Attention deficit disorders * Autism spectrum disorders * Biomedical technology * Cardiology * Dentistry * Diabetes * Diseases, Conditions, Syndromes * Endocrinology & Metabolism * Gastroenterology * Genetics * Gerontology & Geriatrics * Health * Health informatics * HIV & AIDS * Immunology * Inflammatory disorders * Medical economics * Medical research * Medications * Neuroscience * Obstetrics & gynaecology * Oncology & Cancer * Ophthalmology * Other * Overweight & Obesity * Parkinson's & Movement disorders * Pediatrics * Psychology & Psychiatry * Radiology & Imaging * Sleep disorders * Sports medicine & Kinesiology * Surgery * Vaccination * Asthma * Breast cancer * Cardiovascular disease * Chronic obstructive pulmonary disease * Colon cancer * Coronary artery disease * Dementia * Depression * Heart attack * Heart disease * High blood pressure * Influenza * Kidney disease * Leukemia * Lung cancer * Malaria * Melanoma * Multiple sclerosis * Myocardial infarction * Ovarian cancer * Post traumatic stress disorder * Rheumatoid arthritis * Schizophrenia * Skin cancer * Stroke * Type 2 diabetes * Full List >> [INS::INS] * * share this! * 122 * Tweet * Share * Email 1. Home 2. Overweight & Obesity 1. Home 2. Endocrinology & Metabolism * * * --------------------------------------------------------------------- March 6, 2025 The GIST Editors' notes This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects by Krista Conger, Stanford University Medical Center Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects The 12-amino-acid BRP peptide (spheres are atoms and sticks are bonds) suppresses appetite and reduces weight gain in mice and pigs without causing nausea or food aversion. Credit: Katrin Svensson/Stanford Medicine A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide--also known as Ozempic--in suppressing appetite and reducing body weight. Notably, testing in animals also showed that it worked without some of the drug's side effects, such as nausea, constipation and significant loss of muscle mass. The newly discovered molecule, BRP, acts through a separate but similar metabolic pathway and activates different neurons in the brain--seemingly offering a more targeted approach to body weight reduction. "The receptors targeted by semaglutide are found in the brain but also in the gut, pancreas and other tissues," said assistant professor of pathology Katrin Svensson, Ph.D. "That's why Ozempic has widespread effects, including slowing the movement of food through the digestive tract and lowering blood sugar levels. In contrast, BRP appears to act specifically in the hypothalamus, which controls appetite and metabolism." Svensson has co-founded a company to launch clinical trials of the molecule in humans in the near future. Svensson is the senior author of the research, which was published in Nature. Senior research scientist Laetitia Coassolo, Ph.D., is the lead author of the study. The study would not have been possible without the use of artificial intelligence to weed through dozens of proteins in a class called prohormones. Prohormones are biologically inert molecules that become active when they are cleaved by other proteins into smaller pieces called peptides; some of these peptides then function as hormones to regulate complex biological outcomes, including energy metabolism, in the brain and other organs. Each prohormone can be divided in a variety of ways to create a plethora of functional peptide progeny. But with traditional methods of protein isolation, it's difficult to pick peptide hormones (which are relatively rare) out of the biological soup of the much more numerous natural byproducts of protein degradation and processing. The researchers focused on the prohormone convertase 1/3 (also known as PCSK1/3), which separates prohormones at specific amino acid sequences and is known to be involved in human obesity. One of the peptide products is glucagon-like peptide 1, or GLP-1, which regulates appetite and blood sugar levels; semaglutide works by mimicking the effect of GLP-1 in the body. The team turned to artificial intelligence to help them identify other peptides involved in energy metabolism. Peptide Predictor Instead of manually isolating proteins and peptides from tissues and using techniques like mass spectrometry to identify hundreds of thousands of peptides, the researchers designed a computer algorithm they named "Peptide Predictor" to identify typical prohormone convertase cleavage sites in all 20,000 human protein-coding genes. They then focused on genes that encode proteins that are secreted outside the cell--a key characteristic of hormones--and that have four or more possible cleavage sites. Doing so narrowed down the search to 373 prohormones, a manageable number to screen for their biological effects. "The algorithm was absolutely key to our findings," Svensson said. Peptide Predictor predicted that prohormone convertase 1/3 would generate 2,683 unique peptides from the 373 proteins. Coassolo and Svensson focused on sequences likely to be biologically active in the brain. They screened 100 peptides, including GLP-1, for their ability to activate lab-grown neuronal cells. As expected, the GLP-1 peptide had a robust effect on the neuronal cells, increasing their activity threefold over control cells. But a small peptide made up of just 12 amino acids bumped up the cells' activity 10-fold over controls. The researchers named this peptide BRP based on its parent prohormone, BPM/retinoic acid inducible neural specific 2, or BRINP2 (BRINP2-related-peptide). When the researchers tested the effect of BRP on lean mice and minipigs (which more closely mirror human metabolism and eating patterns than mice do), they found that an intramuscular injection of BRP prior to feeding reduced food intake over the next hour by up to 50% in both animal models. Obese mice treated with daily injections of BRP for 14 days lost an average of 3 grams--due almost entirely to fat loss--while control animals gained about 3 grams over the same period. The mice also demonstrated improved glucose and insulin tolerance. Behavioral studies of the mice and pigs found no differences in the treated animals' movements, water intake, anxiety-like behavior or fecal production. And further studies of physiological and brain activity showed that BRP activates metabolic and neuronal pathways separate from those activated by GLP-1 or semaglutide. The researchers hope to identify the cell-surface receptors that bind BRP and to further dissect the pathways of its action. They are also investigating how to help the peptide's effects last longer in the body to allow a more convenient dosing schedule if the peptide proves to be effective in regulating human body weight. "The lack of effective drugs to treat obesity in humans has been a problem for decades," Svensson said. "Nothing we've tested before has compared to semaglutide's ability to decrease appetite and body weight. We are very eager to learn if it is safe and effective in humans." Researchers from the University of California, Berkeley; the University of Minnesota; and the University of British Columbia contributed to the work. Svensson and Coassolo are inventors on patents regarding BRP peptides for metabolic disorders. Svensson is a co-founder of Merrifield Therapeutics. More information: Laetitia Coassolo et al, Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide, Nature (2025). DOI: 10.1038/s41586-025-08683-y Journal information: Nature Provided by Stanford University Medical Center Citation: Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects (2025, March 6) retrieved 7 March 2025 from https://medicalxpress.com/news/ 2025-03-naturally-molecule-rivals-ozempic-weight.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. --------------------------------------------------------------------- Explore further Promising peptide compound can decrease appetite and protect the brain against Alzheimer's-type diseases --------------------------------------------------------------------- 128 shares * Facebook * Twitter * Email Feedback to editors * Featured * Last Comments * Popular Do we see the same red? New qualia structure paradigm measures shared sensory experiences 4 hours ago 0 Study shows that dendritic plasticity contributes to the integration of memories 10 hours ago 0 Better sleep, better blood sugar? Study links sleep patterns to glucose stability 11 hours ago 0 Oral norovirus vaccine passes safety testing with a strong immune response in older adults Mar 6, 2025 0 18-year study shows a rapid rise in alcohol-related organ damage in young Canadian population Mar 6, 2025 0 --------------------------------------------------------------------- [gif] Ammonia buildup kills liver cells but can be prevented using existing drug 4 hours ago [gif] Calcium channel inhibition promotes cardiac regeneration, offering hope for heart failure treatment 4 hours ago [gif] Genome-edited stem cells reveal new hope for obesity treatment without muscle loss 4 hours ago [gif] Do we see the same red? New qualia structure paradigm measures shared sensory experiences 4 hours ago [gif] El Nino, La Nina, and infectious disease: Understanding how ENSO cycles impact immunity and outbreak patterns 6 hours ago [gif] New test distinguishes between prion disease and other causes of rapidly progressive dementia 6 hours ago [gif] ITSN1 gene linked to substantial risk of Parkinson's disease 7 hours ago [gif] Experimental drug found to more than double survival time for glioblastoma patients 8 hours ago [gif] Five-year data support ctDNA liquid biopsies to guide colon cancer treatment 8 hours ago [gif] Student-built app slashes weeks off brain mapping to speed up neuroscience research 8 hours ago [INS::INS] * Related Stories [gif] Promising peptide compound can decrease appetite and protect the brain against Alzheimer's-type diseases Aug 21, 2024 [gif] Peptide boronic acids offer new prospects for synthetic immunology Aug 13, 2024 [gif] Fluorescent peptide nanoparticles, in every color of the rainbow Jul 8, 2020 [gif] Researchers develop deep-learning model that outperforms Google AI system to predict peptide structures Jun 27, 2024 [gif] Peptide could allow medical marijuana to relieve pain without side effects May 12, 2021 [gif] Scientists sustainably create peptide-based medicines, pave way for greener cancer treatments Jul 8, 2024 * Recommended for you [gif] Better sleep, better blood sugar? Study links sleep patterns to glucose stability 11 hours ago [gif] Genome-edited stem cells reveal new hope for obesity treatment without muscle loss 4 hours ago [gif] Early-life gut microbes linked to diabetes protection in mice Mar 6, 2025 [gif] Labrador study uncovers genetic ties to human obesity, highlighting shared pathways Mar 6, 2025 [gif] Detailed enzyme structure offers path to targeted breast cancer drugs Mar 6, 2025 [gif] When you get hurt matters: Circadian rhythms shown to play a role in muscle repair Mar 5, 2025 Load comments (0) Get Instant Summarized Text (Gist) A naturally occurring molecule, BRP, has been identified as a potential alternative to semaglutide (Ozempic) for weight loss, showing similar appetite suppression and weight reduction effects without the side effects like nausea and muscle loss. BRP acts through a distinct metabolic pathway, targeting neurons in the hypothalamus. Animal studies demonstrated significant fat loss and improved glucose tolerance. Researchers aim to explore BRP's mechanisms and potential for human use. This summary was automatically generated using LLM. Full disclaimer Let us know if there is a problem with our content Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines). Please select the most appropriate category to facilitate processing of your request [-- please select one -- ] [ ] [ ] [ ] [ ] [ ] Your message to the editors [ ] Your email (only if you want to be contacted back) [ ] Send Feedback Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages. E-mail the story Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects Your friend's email [ ] Your email [ ] [ ] I would like to subscribe to Science X Newsletter. Learn more Your name [ ] Note Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form. [ ] [ ] [ ] [ ] [ ] [ ] [ ] Your message [ ] Send Newsletter sign up Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties. [ ] Subscribe More information Privacy policy Donate and enjoy an ad-free experience We keep our content available to everyone. Consider supporting Science X's mission by getting a premium account. Remove ads Maybe later Phys.org Phys.org Daily science news on research developments and the latest scientific innovations Tech Xplore Tech Xplore The latest engineering, electronics and technology advances ScienceX Science X The most comprehensive sci-tech news coverage on the web Newsletters [ ] Subscribe Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox Follow us * * * * * * * * Top * Home * Search * Mobile version * Help * FAQ * About * Contact * Science X Account * Premium Account * Newsletter * Archive * Android app * iOS app * RSS feeds * Push notification (c) Medical Xpress 2011 - 2025 powered by Science X Network Privacy policy Terms of use Medical Disclaimer E-mail newsletter [ ] Subscribe Follow us * * * * It appears that you are currently using Ad Blocking software. What are the consequences? x Quantcast